Altaris to Acquire Perrigo’s Prescription Rx Business for $1.55 Billion
March 2, 2021
Cleary Gottlieb represented Altaris Capital Partners on antitrust matters related to its definitive agreement to acquire Perrigo’s prescription pharmaceuticals business for total consideration of $1.55 billion.
The transaction was announced on March 2, 2021.
For more information, please see the press release here.